Pancreatic Cancer Research

ResearcherBaylor College of MedicineActive in the last 2 years

Zachary Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-6668-8181; OpenAlex author ID A5035360596. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 4

  1. Tumor Immune Microenvironment Differences Associated With Racial Disparities in Pancreatic Cancer. Co-author DOI 10.1016/j.jss.2025.01.005↗
  2. Sphingosine-1-Phosphate Inhibition Increases Endoplasmic Reticulum Stress to Enhance Oxaliplatin Sensitivity in Pancreatic Cancer. Co-author DOI 10.14740/wjon1768↗
  3. Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma. Co-author DOI 10.3389/fimmu.2024.1324093↗
  4. Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1274783↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ernest Ramsay Camp · 4 shared papers, 2023–2025 · strength 0.83
  2. Mark P. Rubinstein · 3 shared papers, 2023–2025 · strength 0.62
  3. Derek J. Erstad · 2 shared papers, 2023–2025 · strength 0.41
  4. George Van Buren · 2 shared papers, 2023–2025 · strength 0.41
  5. Shalini Makawita · 1 shared paper, 2024 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.